{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.biotheryx.com/#organization",
      "name": "Biotheryx",
      "url": "https://www.biotheryx.com/",
      "description": "Biotheryx About Us Team Board of Directors Investors Our Science Ubiquitin-Proteasome System Prodegy Platform Publications & Presentations Pipeline News Careers Degrading proteins. About Us ++ Overview Biotheryx is advancing a portfolio of first-in-class protein degraders, with an initial focus on validated targets in cancer and inflammatory disease. Leaders in next-generation targeted protein degrader design and development Learn more Our Science ++ Overview Our PRODEGY ( Pro tein De grader Technolo gy ) platform was designed as a new and powerful targeted protein degradation drug discovery engine."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/biotheryx#asg",
      "name": "Biotheryx ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/biotheryx",
      "isPartOf": {
        "@id": "https://www.biotheryx.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}